Here, we integrate single-cell profiling of diabetic kidney and exosome-based functional intervention to test the hypothesis that MC-derived SFRP2 exacerbates osteoporosis, and reducing SFRP2 expression could serve as an effective therapeutic approach. The gene discussed is SFRP2; the disease is osteoporosis.